Table: Rohto -2022/23 group results

Rohto Pharmaceutical

12/05/2023 07:00

May 12 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            238.66          199.65         259.00                 
                 (+19.5 pct)                    (+8.5 pct)               
  Operating         33.96           29.02          35.00                 
                 (+17.0 pct)                    (+3.1 pct)               
  Recurring         35.57           28.75          36.00                 
                 (+23.7 pct)                    (+1.2 pct)               
  Net
  Net               26.38           21.13          26.50                 
                 (+24.9 pct)                    (+0.5 pct)               
  EPS            115.62 yen       92.61 yen     116.16 yen               
  EPS Diluted    115.29 yen       92.34 yen                              
  Ann Div                         36.00 yen      24.00 yen               
  -Q2 Div         20.00 yen       15.00 yen      12.00 yen               
  -Q4 Div         12.00 yen       21.00 yen      12.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T